Clinical trial
Utility of Oral Dexmedetomidine as the Sole Sedative Agent in Pediatric Population Undergoing MRI
NCT05619627 is registered in ClinicalTrials.gov with Soroush Merchant as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utility of Oral Dexmedetomidine as the Sole Sedative Agent in Pediatric Population Undergoing MRI
- Lead sponsor
- Soroush Merchant
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- November 1, 2026
- Completion date
- March 31, 2028
- Enrollment
- 18 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anesthesia